Molecular probes for multimodality imaging and tracking of stem cells
US-9492571-B2 · Nov 15, 2016 · US
Use of N-(4-isopropylphenyl)-5-amino-isoindoline
US9775920B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9775920-B2 |
| Application number | US-201615223559-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2016 |
| Priority date | Jul 31, 2015 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a novel use of N-(4-isopropylphenyl)-5-amino-isoindoline for diagnosing Alzheimer's disease and quantifying amyloid in the brain.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of diagnosing Alzheimer's disease using a tissue sample from a subject comprising: contacting the tissue sample with a compound labelled with a radioactive element to detect an amyloid in the sample, wherein the compound is represented by Formula (1) below: and detecting the compound bound to the tissue sample. 2. The method according to claim 1 , further comprising quantifying the amount of amylold in the tissue sample. 3. The method according to claim 1 , wherein the radioactive element is C-11 or F-18.
Assignees
Inventors
Classifications
- A61K51/0446Primary
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9775920B2 cover?
- The present invention relates to a novel use of N-(4-isopropylphenyl)-5-amino-isoindoline for diagnosing Alzheimer's disease and quantifying amyloid in the brain.
- Who is the assignee on this patent?
- Inst Nuclear Energy Res Atomic Energy Council Executive Yuan Roc
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0446. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).